LU86020A1 - Du traitement des etats hypotrophiques - Google Patents

Du traitement des etats hypotrophiques Download PDF

Info

Publication number
LU86020A1
LU86020A1 LU86020A LU86020A LU86020A1 LU 86020 A1 LU86020 A1 LU 86020A1 LU 86020 A LU86020 A LU 86020A LU 86020 A LU86020 A LU 86020A LU 86020 A1 LU86020 A1 LU 86020A1
Authority
LU
Luxembourg
Prior art keywords
arginine
treatment
arginine aspartate
dose
children
Prior art date
Application number
LU86020A
Other languages
English (en)
French (fr)
Inventor
Pontagnier Henri
Greuzet Marie-Helene
Original Assignee
Cortial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial filed Critical Cortial
Publication of LU86020A1 publication Critical patent/LU86020A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU86020A 1984-07-24 1985-07-24 Du traitement des etats hypotrophiques LU86020A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8411835 1984-07-24
FR8411835A FR2568124B1 (fr) 1984-07-24 1984-07-24 Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine

Publications (1)

Publication Number Publication Date
LU86020A1 true LU86020A1 (fr) 1986-02-12

Family

ID=9306499

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86020A LU86020A1 (fr) 1984-07-24 1985-07-24 Du traitement des etats hypotrophiques

Country Status (14)

Country Link
JP (1) JPS6137734A (de)
AU (1) AU574811B2 (de)
BE (1) BE902954A (de)
CH (1) CH660689A5 (de)
DE (1) DE3439805C2 (de)
DZ (1) DZ699A1 (de)
FR (1) FR2568124B1 (de)
IT (1) IT1177368B (de)
LU (1) LU86020A1 (de)
MA (1) MA20290A1 (de)
NL (1) NL8502100A (de)
OA (1) OA07878A (de)
PT (1) PT79617A (de)
ZA (1) ZA851683B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019558A (en) * 1988-05-09 1991-05-28 Georges Cehovic Method for treating memory disturbances using arginine aspartate
DE19705233A1 (de) * 1997-02-12 1998-08-13 Froelich Juergen C Verfahren zur Herstellung einer Formulierung enthaltend Arginin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR106F (de) * 1964-12-21
IT1131854B (it) * 1980-06-30 1986-06-25 Baldacci Lab Spa Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare
FR2547501A1 (fr) * 1983-06-15 1984-12-21 Opochimiotherapie Lab Excipient effervescent, sans alcalino-terreux, contenant des composes carbonates de l'arginine et un acide, et comprimes effervescents correspondants

Also Published As

Publication number Publication date
PT79617A (en) 1985-01-01
MA20290A1 (fr) 1985-07-01
DE3439805A1 (de) 1986-02-06
AU574811B2 (en) 1988-07-14
FR2568124A1 (fr) 1986-01-31
DZ699A1 (fr) 2004-09-13
NL8502100A (nl) 1986-02-17
AU4527385A (en) 1986-01-30
FR2568124B1 (fr) 1988-12-09
DE3439805C2 (de) 1994-01-20
JPS6137734A (ja) 1986-02-22
CH660689A5 (fr) 1987-06-15
BE902954A (fr) 1986-01-22
IT8423800A1 (it) 1986-05-29
ZA851683B (en) 1986-01-29
IT1177368B (it) 1987-08-26
OA07878A (fr) 1986-11-20
IT8423800A0 (it) 1984-11-29

Similar Documents

Publication Publication Date Title
US4962121A (en) Method and composition for treating neurological diseases such as migraine
JP2005509004A (ja) 血圧または肺動脈圧を大きく低下させない一酸化窒素ドナーの治療的投薬量の使用
US11560375B2 (en) Composition and method for treating metabolic disorders
US9333191B2 (en) Mast cell stabilizers to prevent or treat laminitis
US6281222B1 (en) Compositions and method for treatment of acetaminophen intoxication
FR2530469A1 (fr) Composition analgesique et anti-inflammatoire contenant de la cafeine
EP2424527A1 (de) Mastzellenstabilisatoren zur prophylaxe oder behandlung von laminitis
KR20080005526A (ko) 가려움증의 치료 또는 예방
LU86020A1 (fr) Du traitement des etats hypotrophiques
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
Kolta et al. Role of 5-hydroxytryptamine in the regulation of brain neuropeptides in normal and diabetic rat
FR2509174A1 (fr) Composition anti-acide a base de n-acetyl-p-aminophenol
EP0630250A1 (de) Pharmazeutische zubereitungen enthaltend monosialogangliosid gm1 oder ein derivat davon zur behandlung des morbus parkinson
US20050118241A1 (en) Platform for transdermal formulations (ptf)
Fitzpatrick et al. Mobilization of renal carnosine and histidine to histamine during compound-48/80-induced shock
JP2022544718A (ja) 敗血症性心筋症を治療するための組成物および方法
FR2845602A1 (fr) Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
PL200928B1 (pl) Zastosowanie kwasu α-liponowego lub jego pochodnych do wytwarzania leku do zapobiegania albo leczenia migreny
JP2001507006A (ja) 糖尿病性血管機能不全の予防のための薬剤の製造へのｃｏｍｔ阻害剤の使用
EP0108017A1 (de) Mischung mit Gehalt an einem Zentral-Analgetikum und an Vitamine B12 oder einem seiner Analoge als Wirkstoffe
EP4340813B1 (de) Verwendung von schilddrüsenhormon t4 in einer behandlung mit hohen vielseitigen eigenschaften bei patienten mit protonenpumpenhemmern
Kakisaka et al. Successful treatment with sumatriptan in a case with cyclic vomiting syndrome combined with 18q—syndrome
Singh et al. Pharmacology of Melatonin and Its Receptors
Vinaik et al. Anabolic and Anticatabolic Agents in Burns
EP0694303A1 (de) Verwendung von Eliprodil und seinen Enantiomeren für die Herstellung von Arzneimitteln zur Prävention von Neuropathien, die durch Wirkstoffe zur Krebsbehandlung, z.B. Paclitaxel, ausgelöst werden

Legal Events

Date Code Title Description
DT Application date
TA Annual fee